Erratum: FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program (Journal of Hepatology (2011) 54 (227-235))

Thierry Poynard, Mona Munteanu, Massimo Colombo, Jordi Bruix, Eugene Schiff, Ruben Terg, Steven Flamm, Ricardo Moreno-Otero, Flair Carrilho, Warren Schmidt, Thomas Berg, Thomas McGarrity, E. Jenny Heathcote, Fernando Gonçales, Moises Diago, Antonio Craxi, Marcelo Silva, Navdeep Boparai, Louis Griffel, Margaret BurroughsClifford Brass, Janice Albrecht

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Hepatology
Volume59
Issue number4
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Hepatology

Cite this

Poynard, T., Munteanu, M., Colombo, M., Bruix, J., Schiff, E., Terg, R., Flamm, S., Moreno-Otero, R., Carrilho, F., Schmidt, W., Berg, T., McGarrity, T., Heathcote, E. J., Gonçales, F., Diago, M., Craxi, A., Silva, M., Boparai, N., Griffel, L., ... Albrecht, J. (2013). Erratum: FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program (Journal of Hepatology (2011) 54 (227-235)). Journal of Hepatology, 59(4). https://doi.org/10.1016/j.jhep.2013.07.006